Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Positive Outlook on WD40 with 313 Price Target

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
Tech-banking-finance
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

On March 5, 2024, analyst Linda Bolton Weiser from DA Davidson reiterated her positive outlook on WD-40 (NASDAQ: WDFC), maintaining a Buy rating and a price target of $313. Amid discussions surrounding the company’s growth targets, DA Davidson has raised questions about the feasibility of WD-40 Co’s ambitious sales projections. Despite concerns about negative free cash flow, WD-40 has shown strong stock performance, with a 12% increase in price since the last quarterly report and a 44.5% surge over the year, outperforming the S&P 500. Looking ahead, Linda Bolton Weiser remains optimistic about WD-40’s potential, highlighting a Strong Buy or Buy rating from top analysts and forecasting an EPS of $5.88 for the upcoming year.

WD-40 Company (WDFC) Stock Price Drops Slightly on March 5, 2024, But Remains Bullish

On March 5, 2024, WD-40 Company (WDFC) experienced a slight drop in its stock price, closing at $266.09. This represents a decrease of $2.20, or 0.82%, from the previous market close. Despite this decline, WDFC is still trading near the top of its 52-week range and above its 200-day simple moving average. This suggests that investors have been bullish on the stock in recent months. Additionally, the fact that WDFC is trading above its 200-day simple moving average is another positive sign for the stock. Despite the slight drop in price on March 5, WDFC has remained relatively stable in after-hours trading, suggesting that investors may not be overly concerned about the price decline and are still confident in the company’s long-term prospects. Overall, WDFC’s performance on March 5, 2024, reflects a stock that is still in a strong position, trading near its highs and showing signs of bullish momentum. Investors will likely continue to monitor the stock closely to see if it can maintain its upward trajectory in the coming days and weeks.

WD-40 Company Reports Mixed Financial Performance for Past Year and Q1 2024

On March 5, 2024, WD-40 Company (WDFC) reported its financial performance for the past year and the first quarter of the current fiscal year. According to data from CNN Money, the company’s total revenue for the past year was $537.25 million, which represents a 3.55% increase compared to the previous year. However, the total revenue for the first quarter of the current fiscal year was $140.42 million, which remained flat compared to the previous quarter.

In terms of net income, WD-40 Company reported a net income of $65.72 million for the past year, which remained flat compared to the previous year. However, the net income for the first quarter of the current fiscal year was $17.42 million, representing a 5.49% increase compared to the previous quarter.

Earnings per share (EPS) for WD-40 Company were reported at $4.83 for the past year, which remained flat compared to the previous year. However, the EPS for the first quarter of the current fiscal year was $1.28, reflecting a 5.59% increase compared to the previous quarter.

Overall, WD-40 Company’s financial performance on March 5, 2024, showed a mixed result. While the total revenue and net income remained relatively stable, there was a slight increase in EPS for the first quarter of the current fiscal year. Investors and analysts will be closely monitoring the company’s performance in the coming quarters.

Tags: WDFC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Myers Industries Stock Surges 13 After Strong Q4 Results and FY24 Guidance

IT-Healthcare

Title Launch of KARDIA3 Trial Evaluating Zilebesiran for Uncontrolled Hypertension

Biopharmaceutical

Exciting Progress for BI1206 in NonHodgkins Lymphoma Treatment

Recommended

Torrid Holdings Stock

Torrid Holdings Faces Critical Earnings Test

5 months ago
Take-Two Stock

Take-Two Shares in Holding Pattern as Investors Await GTA VI Details

6 months ago
Union Pacific Stock

Union Pacific’s Future Hangs in Balance as Historic Railroad Merger Faces Critical Vote

4 months ago
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

Trending

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

by SiterGedge
February 7, 2026
0

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which...

Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success
  • Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com